An open-label phase IIa trial evaluating the safety and efficacy of EPO906 as therapy in patients with advanced renal cancer
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Patupilone (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 17 Nov 2009 Planned number of patients (53) as reported by ClinicalTrials.gov.
- 17 Nov 2009 Planned number of patients (53) as reported by ClinicalTrials.gov.
- 21 Sep 2007 Status change